XHKG
0708
Market cap237mUSD
Mar 31, Last price
0.17HKD
Name
China Evergrande New Energy Vehicle Group Ltd
Chart & Performance
P/E
—
P/S
1.26
EPS
—
Div Yield, %
—
Shrs. gr., 5y
4.65%
Rev. gr., 5y
-18.43%
Revenues
1.34b
+759.96%
Net income
-11.93b
L-62.90%
CFO
-251m
L-89.58%
Dividend
Dec 04, 20140.0013 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Evergrande New Energy Vehicle Group Limited, an investment holding company, operates as a health management company in the People's Republic of China, Europe, and internationally. The company operates through two segments, Health Management and New Energy Vehicle. It develops and sells health and living properties; and provides community health management, medical cosmetology, and anti-aging services, as well as elderly care and rehabilitation. The company is involved in the wholesale of home care and healthcare products, as well as provision of healthcare services and software services. In addition, it engages in the research and development of pharmaceuticals; production of medical equipment; and manufacture and sale of smart mobility and lithium-ion battery. Further, the company is involved in the research, development, production, and sales of new energy vehicles and vehicle living project. The company was formerly known as Evergrande Health Industry Group Limited and changed its name to China Evergrande New Energy Vehicle Group Limited in August 2020. China Evergrande New Energy Vehicle Group Limited was founded in 1999 and is headquartered in Guangzhou, China. China Evergrande New Energy Vehicle Group Limited is a subsidiary of China Evergrande Group.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||